Comparison of the effects of two doses of betamethasone with different intervals on dyspnea of preterm neonates

Comparison of the effects of two doses of betamethasone with different intervals on respiratory distress syndrome of preterm neonates

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015090123851N1

Enrollment

200

Registered

2015-10-30

Start date

2015-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Betamethasone, 12 mg, two times with a 24 hours interval, intravenously. Intervention 2: Betamethasone, 12 mg, two times with a 12 hours interval, intravenously.

Prevention

Betamethasone, 12 mg, two times with a 24 hours interval, intravenously.

Betamethasone, 12 mg, two times with a 12 hours interval, intravenously.

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient satisfaction; Women with preterm labor; Gestational age between 25 to 34 weeks. Exclusion criteria: Fetal distress; Chorioamnionitis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Respiratory distress syndrome of newborn. Timepoint: After labor. Method of measurement: Qualitative.;Umbilical cord pH. Timepoint: After labor. Method of measurement: Quantitative.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Saeideh Bagherbandi

Shahid Beheshti University of Medical Sciences

Bagherbandi.sa@sbmu.ac.ir+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026